 |
|
|
| |
Effect of Demographic and Baseline Disease Characteristics on the Efficacy and Safety of Daclatasvir in Combination With Asunaprevir in Japanese Patients With HCV Genotype 1b Infection
|
| |
| |
Reported by Jules Levin
2014 Annual Meeting of the Asian Pacific Association for the Study of the Liver Brisbane, Australia, March 12Ð15, 2014
Y Kawakami,1 K Chayama ,1 Y Suzuki,2 K Ikeda,2 J Toyota,3 Y Karino,3 A Ido,4 K Yamamoto,5 K Takaguchi,6 H Miyagoshi,7 T Eley,8 F McPhee,8 W Hu,8 H Ishikawa,7 EA Hughes,8 H Kumada2
1Hiroshima University, Hiroshima, Japan; 2Toranomon Hospital, Tokyo, Japan; 3Sapporo-Kosei General Hospital, Sapporo, Japan; 4Kagoshima University, Kagoshima, Japan; 5Okayama University, Okayama, Japan; 6Kagawa Prefectural Hospital, Kagawa, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol-Myers Squibb Research & Development, Princeton, NJ, USA
|
| |
|
|
|
|
|
